why-choose-biomymesis

NEWS
News
New investment by GO CAPITAL and NCIS in CELE…
18/05/2016
After investing one million euros in 2014, GO CAPITAL and NCI are investing a further € 500,000 in CELENYS, € 350,000 by the FPCI GO CAPITAL Amorçage and € 150,000 by the…
+
image4144
CELENYS will present 3D cell automation sessi…
03/05/2016
CELENYS’ mission is to develop scaffolds for 3D cell culture to better mimic the tissue microenvironment and provide more predictive in vitro tools for drug development.…
+